QCM
TMO icon

Quest Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

Quest Capital Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		$813K Buy
1,219
+4
+0.3% +$2.5K 0.14% 106
2021
Q3 		$694K Buy
1,215
+80
+7% +$43.9K 0.14% 104
2021
Q2 		$573K Buy
1,135
+197
+21% +$93K 0.11% 121
2021
Q1 		$428K Sell
938
-79
-8% -$37.7K 0.09% 140
2020
Q4 		$474K Buy
1,017
+85
+9% +$39.9K 0.11% 114
2020
Q3 		$411K Buy
932
+8
+0.9% +$3.31K 0.11% 115
2020
Q2 		$335K Buy
924
+12
+1% +$4.02K 0.1% 127
2020
Q1 		$259K Buy
912
+101
+12% +$31.8K 0.09% 137
2019
Q4 		$263K Buy
811
+1
+0.1% +$303 0.06% 169
2019
Q3 		$236K Sell
810
-53
-6% -$15.2K 0.06% 188
2019
Q2 		$253K Buy
863
+113
+15% +$31.1K 0.06% 175
2019
Q1 		$205K Buy
+750
New +$187K 0.05% 197

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Quest Capital Management's TMO Position: Q4 2021 in Review

Quest Capital Management increased its Thermo Fisher Scientific (TMO) stake by 0.33% in Q4 2021, buying an estimated $2.5K and bringing the position to 1,219 shares worth $813K. The position accounts for 0.14% of the portfolio, ranked #106.

Quest Capital Management first reported a position in TMO in Q1 2019 and has held it in 12 quarters since. 2,342 funds tracked by Wall St. Rank hold TMO as of Q4 2021.

  • Quest Capital Management held 1,219 shares of Thermo Fisher Scientific worth $813K as of Q4 2021.
  • Quest Capital Management bought 4 Thermo Fisher Scientific shares in Q4 2021, an estimated $2.5K.
  • Thermo Fisher Scientific made up 0.14% of Quest Capital Management's portfolio in Q4 2021, its #106 holding.
  • Quest Capital Management first reported a position in Thermo Fisher Scientific in Q1 2019 and has held it in 12 quarters since.
  • 2,342 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q4 2021.

Based on Quest Capital Management's 13F filing for Q4 2021, filed 31 Jan 2022.